New Delhi, Delhi
GST No. 07AAKFN5053A1ZK
Call 08048982480 88% Response Rate
Send Enquiry
Product Brochure
| Dose/Strength | 200 mg |
| Form | Injection |
| Prescription/Non prescription | Prescription |
| Composition | Gemcitabine |
| Packaging Size | vial |
| Manufacturer | Dr.reddys |
View Complete details
| Dose/Strength | 1000 mg |
| Packaging Type | Box |
| Manufacturer | Medicamen Biotech Ltd |
| Prescription/Non-prescription | Prescription-only. |
| Brand Name | Gemivo |
Gemcitabine, the active ingredient in Gemivo 1gm Injection, is an anticancer agent used to treat various types of cancer, including:
Non-Small Cell Lung Cancer (NSCLC): Administered alone or in combination with cisplatin.
Breast Cancer: Combined with paclitaxel after prior anthracycline-containing chemotherapy has failed.
Pancreatic Cancer: Used as a single agent.
Ovarian Cancer: Used with carboplatin for patients who have relapsed at least 6 months after completing platinum-based therapy.
Urinary Bladder Cancer: Combined with cisplatin.
Gemcitabine works by interfering with the DNA synthesis of cancer cells, thereby inhibiting their growth and proliferation. The dosage and administration schedule depend on the type of cancer being treated and the patient's medical condition. Common side effects include low white blood cell count, nausea, vomiting, fever, and fatigue. Close monitoring of blood cell counts and organ function is essential during treatment. This medication should be administered under the supervision of a qualified healthcare professional experienced in cancer chemotherapy.
View Complete details
| Dose/Strength | 1000 mg |
| Packaging Type | Vial |
| Manufacturer | Hetero Healthcare Limited |
| Brand Name | Gemtero |
| Prescription/Non-prescription | Prescription-only. |
Gemcitabine, the active ingredient in Gemtero 1g Injection, is an anticancer agent used to treat various types of cancer, including:
Non-Small Cell Lung Cancer (NSCLC): Administered alone or in combination with cisplatin.
Breast Cancer: Combined with paclitaxel after prior anthracycline-containing chemotherapy has failed.
Pancreatic Cancer: Used as a single agent.
Ovarian Cancer: Used with carboplatin for patients who have relapsed at least 6 months after completing platinum-based therapy.
Urinary Bladder Cancer: Combined with cisplatin.
Gemcitabine works by interfering with the DNA synthesis of cancer cells, thereby inhibiting their growth and proliferation. The dosage and administration schedule depend on the type of cancer being treated and the patient's medical condition. Common side effects include low white blood cell count, nausea, vomiting, fever, and fatigue. Close monitoring of blood cell counts and organ function is essential during treatment. This medication should be administered under the supervision of a qualified healthcare professional experienced in cancer chemotherapy.
View Complete details
Product Brochure
| Dose/Strength | 1,1.5 gm |
| Packaging Type | Vial |
| Prescription/Non prescription | Prescription |
| Usage/Application | Clinical |
| Composition | Gemcitabine |
| Brand | MYGEM |
| Manufacturer | MYLAN |
Additional Information:
View Complete details
| Dose/Strength | 200 mg |
| Packaging Type | Vial |
| Manufacturer | Khandelwal Laboratories Pvt. ltd |
| Brand name | Gempower |
| Prescription/Non-prescription | Prescription |
View Complete details